4k26: Difference between revisions

@@ Line 1: / Line 1: @@
-'''Unreleased structure'''
+{{STRUCTURE_4k26|  PDB=4k26  |  SCENE=  }}
+===4,4-Dioxo-5,6-dihydro-[1,4,3]oxathiazines, a novel class of 11 -HSD1 inhibitors for the treatment of diabetes===
+{{ABSTRACT_PUBMED_23845218}}
-The entry 4k26 is ON HOLD  until Apr 08 2015
+==Function==
+[[http://www.uniprot.org/uniprot/DHI1_MOUSE DHI1_MOUSE]] Catalyzes reversibly the conversion of cortisol to the inactive metabolite cortisone.
-Authors: Loenze, P., Schimanski-Breves, S., Vonderheyden, C., Engel, C.K.
+==About this Structure==
+[[4k26]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4K26 OCA].
-Description: 4,4-Dioxo-5,6-dihydro-[1,4,3]oxathiazines, a novel class of 11 -HSD1 inhibitors for the treatment of diabetes
+==Reference==
+<ref group="xtra">PMID:023845218</ref><references group="xtra"/><references/>
+[[Category: 11-beta-hydroxysteroid dehydrogenase]]
+[[Category: Engel, C K.]]
+[[Category: Loenze, P.]]
+[[Category: Schimanski-Breves, S.]]
+[[Category: Vonderheyden, C.]]
+[[Category: Alpha and beta protein]]
+[[Category: Oxidoreductase]]
+[[Category: Oxidoreductase-oxidoreductase inhibitor complex]]
+[[Category: Short chain dehydrogenase]]

Navigation menu